Gencor ~ Intelicaps® Technology

ANAHEIM, Calif.Gencor entered the probiotics market with its new Intelicaps® technology, which embeds probiotics in stable microspheres.

The company's new technology maintains product stability under extreme conditions, allowing for a wide range of applications. Due to layer-by-layer coating, the probiotics are protected against environmental impacts and benefit from long-lasting stabilization. Microcapsules resist low pH levels, allowing them to pass through the stomach without opening, and they deliver the viable probiotics directly to the intestine, which is the target organ.

Previously, probiotics existed in only one formulationlyophilized probiotics in powder form," said Jith Veeravalli, president of Gencor. "But the Intelicaps technology makes possible numerous formulations, including simple tablets and chewables, as well as safe combinations with substances such as zinc, citrate and vitamin C. Additionally, the fermented strains may be used in production like a traditional ingredient, without significant reduction in quality."

Developed by Vesale Pharma, the Intelicaps technology is designed to address the problem of the low viability of probiotics. Probiotics are intended to colonize the human intestine in large numbers, so their survival rate is essential for an effect on health. Lyophilized probiotics are delicate organisms whose viability is influenced by factors such as pH, humidity, heat, temperature fluctuations and exposure to oxygen. 

Gencor started it's business as a nutraceutical ingredient supplier in 2002, and it has established relationships with suppliers in Hong Kong, India, China, South Africa and companies in South America.